IL231097A0 - N-[4-(1h-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals - Google Patents

N-[4-(1h-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals

Info

Publication number
IL231097A0
IL231097A0 IL231097A IL23109714A IL231097A0 IL 231097 A0 IL231097 A0 IL 231097A0 IL 231097 A IL231097 A IL 231097A IL 23109714 A IL23109714 A IL 23109714A IL 231097 A0 IL231097 A0 IL 231097A0
Authority
IL
Israel
Prior art keywords
pyrazin
pyrazolo
sulfonamides
pharmaceuticals
phenyl
Prior art date
Application number
IL231097A
Other languages
Hebrew (he)
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of IL231097A0 publication Critical patent/IL231097A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL231097A 2011-09-19 2014-02-23 N-[4-(1h-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals IL231097A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2011/066220 WO2013041119A1 (en) 2011-09-19 2011-09-19 N-[4-(1h-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals

Publications (1)

Publication Number Publication Date
IL231097A0 true IL231097A0 (en) 2014-03-31

Family

ID=44799999

Family Applications (1)

Application Number Title Priority Date Filing Date
IL231097A IL231097A0 (en) 2011-09-19 2014-02-23 N-[4-(1h-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals

Country Status (6)

Country Link
KR (1) KR20140064975A (en)
AU (1) AU2011377409B2 (en)
CA (1) CA2846369C (en)
IL (1) IL231097A0 (en)
SG (1) SG11201400551UA (en)
WO (1) WO2013041119A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2570415E (en) 2011-09-19 2015-11-23 Sanofi Sa N-[4-(1h-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals
US20130072493A1 (en) 2011-09-19 2013-03-21 Sanofi N-[4-(1H-PYRAZOLO[3,4-b]PYRAZIN-6-YL)-PHENYL]-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS
TWI629275B (en) * 2013-03-13 2018-07-11 賽諾菲公司 N-(4-azaindazol-6-yl)-phenyl)-sulfonamides and their use as pharmaceuticals
US9974788B2 (en) 2013-09-26 2018-05-22 Beth Israel Deaconess Medical Center, Inc. Inhibition of SGK1 in the treatment of heart conditions
WO2018106459A1 (en) 2016-12-07 2018-06-14 New Era Pharma, Inc. Compounds and pharmaceutical compositions for modulating sgk activity, and methods thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6690240B2 (en) 2002-01-10 2004-02-10 Cirrus Logic, Inc. Low-jitter loop filter for a phase-locked loop system
AU2004274403A1 (en) 2003-09-03 2005-03-31 Aventis Pharmaceuticals Inc. 5-aryl-Pyrazolo(4,3-d)pyrimidines, pyridines, and pyrazines and related compounds
DE102005015255A1 (en) * 2005-04-04 2006-10-05 Merck Patent Gmbh New acylhydrazide compounds are signal transduction kinase inhibitor, useful for treating and/or preventing diseases, e.g. diabetes, adiposity, metabolic syndrome, cancer and tumor cells
DE102006043443A1 (en) 2006-09-15 2008-03-27 Bayer Healthcare Ag Novel aza-bicyclic compounds and their use
DE102007002717A1 (en) * 2007-01-18 2008-07-24 Merck Patent Gmbh Heterocyclic indazole derivatives

Also Published As

Publication number Publication date
KR20140064975A (en) 2014-05-28
AU2011377409A1 (en) 2014-03-20
AU2011377409B2 (en) 2017-05-25
CA2846369C (en) 2018-11-13
WO2013041119A1 (en) 2013-03-28
SG11201400551UA (en) 2014-04-28
CA2846369A1 (en) 2013-03-28

Similar Documents

Publication Publication Date Title
PL2570415T3 (en) N-[4-(1H-Pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals
EP2751112A4 (en) Substituted pyrazolo[3,4-d]pyrimidines and uses thereof
HK1198698A1 (en) Substituted annellated pyrimidine and the use thereof
HK1198442A1 (en) Pyrazolopyridine derivatives, preparation process therefor and therapeutic use thereof
ZA201404294B (en) Substituted 1,2,5-oxadiazole compounds and their use as herbicides
IL250370A0 (en) 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
HK1193100A1 (en) Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament -3--[310]-3--
EP2688688A4 (en) Aqueous, nitrogen-free cleaning composition, preparation and use thereof
IL249825A0 (en) Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
IL231097A0 (en) N-[4-(1h-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals
EP2757092A4 (en) Substituted cyanoaniline compounds, preparation and use thereof
EP2551259A4 (en) Sitagliptin intermediate compounds, preparation methods and uses thereof
EP2778168A4 (en) Pyrrolo pyrroledione-thenequinone compound, and preparation process and use thereof
HK1205504A1 (en) Substituted pyrazolo[1,5-a]pyridines, their preparation and use as medicaments [1,5-a]
GB201119286D0 (en) Agrochemical formulation and use thereof
HRP20160687T1 (en) Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals
IL232809A (en) Isothiazolopyridine-2-carboxamides and their use as pharmaceuticals
IL231096A (en) Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals
Lee et al. Model Kits and Spatial Ability